CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 
 

CADL's Net Income Growth by Quarter and Year

Candel Therapeutics Inc 's Net Income results by quarter and year




CADL Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.00
III Quarter September -16.16 0.00 0.00 0.00
II Quarter June -17.08 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -33.24 - - -



CADL Net Income third quarter 2021 Y/Y Growth Comment
Candel Therapeutics Inc in the third quarter recorded net loss of $ -16.16 millions.

According to the results reported in the third quarter, Candel Therapeutics Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Candel Therapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter.




CADL Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Candel Therapeutics Inc 's third quarter 2021 Net Income $ -16.16 millions CADL's Income Statement
Candel Therapeutics Inc 's third quarter 2020 Net Income $ 0.00 millions Quarterly CADL's Income Statement
New: More CADL's historic Net Income Growth >>


CADL Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Candel Therapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CADL's III. Quarter Q/Q Net Income Comment
Even if Candel Therapeutics Inc in the III. Quarter 2021 showed net loss of $ -16.16 millions, some analyst said, that this point to recovery in contrast to the -17.08 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Candel Therapeutics Inc achieved highest sequential Net Income growth. While Candel Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CADL's III. Quarter Q/Q Net Income Comment
Even if Candel Therapeutics Inc in the III. Quarter 2021 showed net loss of $ -16.16 millions, management said, that this are slight up side in contrast to the -17.08 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Candel Therapeutics Inc achieved highest sequential Net Income growth. While Candel Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Candel Therapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Net Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
In the Sep 30 2021 period, Candel Therapeutics Inc 's cumulative trailing twelve month Net Income remained unchanged compare to the same period a year ago.

Candel Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
In the Sep 30 2021 period, Candel Therapeutics Inc 's cumulative trailing twelve month Net Income remained unchanged compare to the same period a year ago.

Candel Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CADL's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CADL's Competitors
Net Income Growth for Candel Therapeutics Inc 's Suppliers
Net Income Growth for CADL's Customers

You may also want to know
CADL's Annual Growth Rates CADL's Profitability Ratios CADL's Asset Turnover Ratio CADL's Dividend Growth
CADL's Roe CADL's Valuation Ratios CADL's Financial Strength Ratios CADL's Dividend Payout Ratio
CADL's Roa CADL's Inventory Turnover Ratio CADL's Growth Rates CADL's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2021
Dexcom Inc -1.80%$ -1.801 millions
Owens and Minor Inc -4.24%$ -4.236 millions
United Therapeutics Corporation-4.96%$ -4.965 millions
Amgen Inc -6.78%$ -6.779 millions
Quidel Corporation-7.11%$ -7.111 millions
Eli Lilly And Company-8.13%$ -8.135 millions
Abiomed Inc -8.45%$ -8.455 millions
Universal Health Services Inc -10.13%$ -10.126 millions
U S Physical Therapy Inc-10.40%$ -10.404 millions
Quest Diagnostics Inc-10.83%$ -10.829 millions
Lemaitre Vascular Inc-13.43%$ -13.430 millions
Vyne Therapeutics Inc -13.87%$ -13.875 millions
Semler Scientific inc -14.71%$ -14.714 millions
Pro dex Inc -15.89%$ -15.889 millions
Laboratory Corporation Of America Holdings-16.47%$ -16.470 millions
Bristol Myers Squibb Co-17.36%$ -17.359 millions
Electromed Inc -17.98%$ -17.984 millions
Nature s Sunshine Products inc -23.87%$ -23.867 millions
Immune Therapeutics Inc -23.97%$ -23.971 millions
Petmed Express Inc-24.52%$ -24.524 millions
Co diagnostics Inc -27.05%$ -27.051 millions
Elite Pharmaceuticals Inc -27.59%$ -27.587 millions
Collegium Pharmaceutical inc -28.71%$ -28.708 millions
Biodelivery Sciences International Inc -28.92%$ -28.925 millions
Stryker Corp-29.47%$ -29.469 millions
Fitlife Brands Inc -31.61%$ -31.611 millions
Hologic Inc-33.29%$ -33.293 millions
Msa Safety Inc-33.33%$ -33.332 millions
Steris Plc-34.32%$ -34.321 millions
Viemed Healthcare Inc -36.20%$ -36.198 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IWSY's Profile

Stock Price

IWSY's Financials

Business Description

Fundamentals

Charts & Quotes

IWSY's News

Suppliers

IWSY's Competitors

Customers & Markets

Economic Indicators

IWSY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071